THE MuSK Trial

Have you or someone you know been diagnosed with myasthenia gravis?

A clinical trial is investigating a new treatment option and is looking for participants.

 

Patients

Enroll in

THE MuSK Trial

THE MuSK Trial is a phase 3 trial evaluating amifampridine phosphate as a treatment for patients with muscle-specific receptor MuSK-MG kinase myasthenia gravis (MuSK-MG).

If you or someone you know has been diagnosed with MuSK-MG or has received a positive anti-AChR antibody test, amifampridine phosphate may help reduce symptoms.

Physicians

THE MuSK Trial 

needs your help

THE MuSK Trial will evaluate the efficacy and safety of amifampridine phosphate in improving the activities of daily living for patients with MuSK-MG.

The trial will enroll approximately 70 participants (~60 participants with anti-MuSK antibodies and ~10 participants with anti-AChR antibodies). If any of your patients meet the trial’s eligibility criteria, please inform them about amifampridine phosphate and THE MuSK Trial.

AChR=acetylcholine receptor; MuSK-MG=muscle-specific receptor tyrosine kinase myasthenia gravis.

Contact us to learn more about

THE MuSK Trial

Toll-free number:

1.844.347.3277

Or go to:

THE MuSK Trial

Have you or someone you know been diagnosed with myasthenia gravis?

A clinical trial is investigating a new treatment option and is looking for participants.

 

Patients

Enroll in THE MuSK Trial

THE MuSK Trial is a phase 3 trial evaluating amifampridine phosphate as a treatment for patients with MuSK-MG kinase myasthenia gravis (MuSK-MG).

If you or someone you know has been diagnosed with MuSK-MG or has received a positive anti-AChR antibody test, amifampridine phosphate may help reduce symptoms.

THE MuSK Trial patient brochure

Physicians

THE MuSK Trial needs your help

THE MuSK Trial will evaluate the efficacy and safety of amifampridine phosphate in improving the activities of daily living for patients with MuSK-MG.

The trial will enroll approximately 70 participants (~60 participants with anti-MuSK antibodies and ~10 participants with anti-AChR antibodies). If any of your patients meet the trial’s eligibility criteria, please inform them about amifampridine phosphate and THE MuSK Trial.

AChR=acetylcholine receptor; MuSK-MG=muscle-specific receptor tyrosine kinase myasthenia gravis.

THE MuSK Trial physician brochure

Contact us to learn more about THE MuSK Trial

E-mail:

MuSKMG@catalyst.com

Toll-free number:

1.844.347.3277

Or go to: